Yildiz-Oren Ilkay, Tekiner-Gulbas Betul, Yalcin Ismail, Temiz-Arpaci Ozlem, Aki-Sener Esin, Altanlar Nurten
Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Tandogan, Ankara, Turkey.
Arch Pharm (Weinheim). 2004 Jul;337(7):402-10. doi: 10.1002/ardp.200300851.
A series of 23 new 2-[p-substituted-benzyl]-5-[p-substituted-phenyl/benzyl-carbonylamino]benzoxazole derivatives has been synthesized by reacting 5-amino-2-[p-substituted-benzyl]benzoxazoles with the appropriate carboxylic acid chlorides. The structures of the synthesized compounds were confirmed by IR and (1)H-NMR spectral data. Antimicrobial activities of the compounds were investigated using the twofold serial dilution technique against two gram-positive and two gram-negative bacteria and three Candida species in comparison with standard drugs. Microbiological results indicated that the newly synthesized 2-[p-substituted-benzyl]-5-[p-substituted-phenyl/benzyl-carbonylamino]benzoxazole derivatives (3-25) possessed a broad spectrum of activity, showing MIC values of 6.25-200 microg/mL against the gram-positive and gram-negative microorganisms tested. Moreover, they showed significant antifungal activity with MIC values of 3.12-100 microg/mL against the Candida species tested. Especially, with a MIC value of 3.12 microg/mL, 2-benzyl-5-[p-bromobenzyl-carbonylamino]benzoxazole 9 displayed the same activity against C. glabrata as the standard drug myconazol.
通过使5-氨基-2-[对取代苄基]苯并恶唑与适当的酰氯反应,合成了一系列23种新的2-[对取代苄基]-5-[对取代苯基/苄基羰基氨基]苯并恶唑衍生物。通过红外光谱和(1)H-NMR光谱数据确认了合成化合物的结构。与标准药物相比,使用两倍系列稀释技术研究了这些化合物对两种革兰氏阳性菌、两种革兰氏阴性菌和三种念珠菌属的抗菌活性。微生物学结果表明,新合成的2-[对取代苄基]-5-[对取代苯基/苄基羰基氨基]苯并恶唑衍生物(3-25)具有广泛的活性,对所测试的革兰氏阳性和革兰氏阴性微生物的最低抑菌浓度(MIC)值为6.25-200μg/mL。此外,它们对所测试的念珠菌属显示出显著的抗真菌活性,MIC值为3.12-100μg/mL。特别是,2-苄基-5-[对溴苄基羰基氨基]苯并恶唑9对光滑念珠菌的MIC值为3.12μg/mL,与标准药物咪康唑具有相同的活性。